immatics biotechnologies GmbH (4A3) — Free Cash Flow Generation Index
immatics biotechnologies GmbH (4A3) has a Free Cash Flow Generation Index of 0.88x as of December 2023. Free cash flow of €69.78 Million represents 1% of operating cash flow (€79.08 Million). Read total liabilities of immatics biotechnologies GmbH for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
immatics biotechnologies GmbH Free Cash Flow Generation Index (2018–2023)
Historical FCF Generation Index trend for immatics biotechnologies GmbH across 6 annual periods. Explore immatics biotechnologies GmbH capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for immatics biotechnologies GmbH (2018–2023)
Year-by-year Free Cash Flow Generation Index for immatics biotechnologies GmbH. For the full company profile including market capitalisation, see immatics biotechnologies GmbH stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.70x | €-12.73 Million | €18.23 Million | €30.96 Million | ▼ -174.5% |
| 2022 | 0.94x | €93.92 Million | €100.13 Million | €5.74 Million | ▲ +207.4% |
| 2021 | -0.87x | €-87.44 Million | €100.13 Million | €5.11 Million | ▲ +6.1% |
| 2020 | -0.93x | €-93.13 Million | €100.13 Million | €7.42 Million | ▼ -196.0% |
| 2019 | 0.97x | €68.73 Million | €70.97 Million | €2.14 Million | ▼ -0.7% |
| 2018 | 0.98x | €20.18 Million | €20.68 Million | €429.00K | — |